Member Info for Rudey

Snap!

CF must be disappointed to have to release an RNS while this overhang remains. He's not the only one :(

https://otp.tools.investis.com/clients/uk/open_orphan/rns/regulatory-story.aspx?cid=2484&newsid=1379101

Mind you, it's been a port and whisky afternoon in my garden, for me and......me.

I thought we'd got 62% of 100% of PrEPBiopharm, not 62% of 50%?

Very well put KTRB.
I hadn't done a lot of research on the potential components to the bundle other than Imutex that could be vended into a NASDAQ company (PrEPBiopharm and our own immune modulator), but this could really be very interesting.
Maybe the cleverer posters on here would look at Midatech (MTPH) to see if their assets could significantly add to this little bundle. Ten-bagger mentioned them previously - they are NASDAQ listed and available for sale.

49% soggy. It's part of Imutex.

Thanks wallyj, and sportstrader. Excellent news.

I'm a bit confused sportstrader. The Fox report states:
Dr. Jessica Manning, overseas clinical researcher for the U.S. National Institute of Allergy and Infectious Diseases, and her colleagues led the study.
In the double-blind study, 49 healthy participants were enrolled at the National Institutes of Health Clinical Center in Bethesda, Md.

Is that definitely ours sportstrader? There's reference to a clinic in Bethesda, USA?

Personally, I don't think it will stay at 'this level' for very long Valhalla, not that it affects me because I'm not trading, I'm invested, fwiw. But if your strategy is to pour cold water on the share price rise, that is a matter between you and your conscience. Hopefully investors won't think you make such statements for their benefit, but for your own, hoping to delay those who are thinking of investing.

WTF? 22nd May! I've seen some delayed trades before, but surely that can't be within the rules.

Pffffssstttt. Below placing share price. lol

I concur Antifragile, but for me the comparison was watching England play cricket test matches on teletext.

I like the idea of selling Imutex for £150m, but I find the idea of NASDAQ listing very exciting - could be huge.

I don't know anything about the MHRA ethics committee, but you'd hope they would use a bit of common sense. Volunteers for the trials are potentially saving half a million lives.

Needs MHRA approval I believe.

Thanks Sportstrader.

Prick.

A nice round number - not.

Looks like the tail end to me.